TY  - JOUR
AU  - Vallejo Casas, Juan Antonio
AU  - Sambo, Marcel
AU  - Lopez Lopez, Carlos
AU  - Duran-Poveda, Manuel
AU  - Rodriguez-Villanueva Garcia, Julio
AU  - Santos, Rita Joana
AU  - Llanos, Marta
AU  - Navarro-Gonzalez, Elena
AU  - Aller, Javier
AU  - Pubul, Virginia
AU  - Guadalix, Sonsoles
AU  - Crespo, Guillermo
AU  - Gonzalez, Cintia
AU  - Zafon, Carles
AU  - Navarro, Miguel
AU  - Santamaria-Sandi, Javier
AU  - Segura, Angel
AU  - Gajate, Pablo
AU  - Gomez-Balaguer, Marcelino
AU  - Valdivia, Javier
AU  - Puig-Domingo, Manel
AU  - Galofre, Juan Carlos
AU  - Castelo, Beatriz
AU  - Villanueva, Maria Jose
AU  - Argüelles, Iñaki
AU  - Orcajo-Rincon, Lorenzo
PY  - 2022
DO  - 10.1530/ETJ-21-0111
SN  - 2235-0640
UR  - http://hdl.handle.net/10668/20449
T2  - European thyroid journal
AB  - Up to 30% of differentiated thyroid cancer (DTC) will develop advanced-stage disease (aDTC) with reduced overall survival (OS). The aim of this study is to characterize initial diagnosis of aDTC, its therapeutic management, and prognosis in Spain and...
LA  - en
PB  - BioScientifica
KW  - Advanced differentiated thyroid cancer
KW  - Epidemiological study
KW  - Radioiodine-refractory differentiated thyroid cancer
KW  - Relapsing differentiated thyroid cancer
KW  - Relapsing prognostic factors
KW  - Survival prognostic factors
KW  - Iodine radioisotopes
KW  - Portugal
KW  - Spain
KW  - Progression-free survival
KW  - Prospective studies
KW  - Thyroid neoplasms
KW  - Adenocarcinoma
KW  - Chronic disease
TI  - Initial clinical and treatment patterns of advanced differentiated thyroid cancer: ERUDIT study.
TY  - research article
VL  - 11
ER  -